BioAdaptives, Inc. (BDPT)
- Previous Close
0.0005 - Open
0.0005 - Bid --
- Ask --
- Day's Range
0.0004 - 0.0005 - 52 Week Range
0.0003 - 0.0060 - Volume
28,131,258 - Avg. Volume
36,582,752 - Market Cap (intraday)
486,080 - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BioAdaptives, Inc. investigates, markets, and distributes natural plant and algal-based products for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance to stress, activates primitive cells, enhances wound healing, and promotes hair and nail growth; and ProteinNMore, which builds lean bulk muscle, and promotes muscle contractility and strength, as well as helps in improving blood flow. It also provides animal products, including Canine All-in-One and Equine All-in-One products for dogs and horses. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
www.shopbioadaptives.com3
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BDPT
Performance Overview: BDPT
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BDPT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BDPT
Valuation Measures
Market Cap
437.47k
Enterprise Value
706.38k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.81
Price/Book (mrq)
--
Enterprise Value/Revenue
24.73
Enterprise Value/EBITDA
-1.35
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-202.50%
Return on Equity (ttm)
--
Revenue (ttm)
28.57k
Net Income Avi to Common (ttm)
-712.47k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
60.78k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
208.62k
Company Insights: BDPT
BDPT does not have Company Insights